Vol 71, No 2 (2021)
Invited editorial
Published online: 2021-04-06

open access

Page views 501
Article views/downloads 426
Get Citation

Connect on Social Media

Connect on Social Media

Rectal NET treatment – current approach

Maciej Matyja1, Michał Pędziwiatr1
Nowotwory. Journal of Oncology 2021;71(2):117-118.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Dasari A, Shen C, Halperin D, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017; 3(10): 1335–1342.
  2. Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015; 50(1): 58–64.
  3. Bertani E, Ravizza D, Milione M, et al. Neuroendocrine neoplasms of rectum: A management update. Cancer Treat Rev. 2018; 66: 45–55.
  4. Radulova-Mauersberger O, Stelzner S, Witzigmannn H. [Rectal neuroendocrine tumors: surgical therapy]. Chirurg. 2016; 87(4): 292–297.
  5. Boškoski I, Volkanovska A, Tringali A, et al. Endoscopic resection for gastrointestinal neuroendocrine tumors. Expert Rev Gastroenterol Hepatol. 2013; 7(6): 559–569.
  6. Konishi T, Watanabe T, Kishimoto J, et al. Japanese Society for Cancer of the Colon and Rectum. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007; 56(6): 863–868.
  7. Shields CJ, Tiret E, Winter DC, et al. International Rectal Carcinoid Study Group. Carcinoid tumors of the rectum: a multi-institutional international collaboration. Ann Surg. 2010; 252(5): 750–755.
  8. Tierney JF, Chivukula SV, Wang X, et al. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2019; 165(3): 644–651.
  9. Zubaryev M, Kim HS, Min BS. Local excision vs. radical surgery in treating rectal nets considering the biology of neuroendocrine tumors (NETs). Nowotwory. Journal of Oncology. 2021; 71(1): 9–16.
  10. Ziv Y, Zbar A, Bar-Shavit Y, et al. Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations. Tech Coloproctol. 2013; 17(2): 151–162.
  11. Eto K, Yoshida N, Iwagami S, et al. Surgical treatment for gastrointestinal neuroendocrine tumors. Ann Gastroenterol Surg. 2020; 4(6): 652–659.